Concepedia

Publication | Closed Access

Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.

101

Citations

37

References

2012

Year

Hongyu Liu, Christian Schölz, Chuanbing Zang, Jan H. Schefe, Piet Habbel, Anne C. Regierer, Carsten‐Oliver Schulz, Kurt Possinger, Jan Eucker
PubMed

Abstract

Our investigation provides a rationale for the clinical application of metformin within treatment regimens for breast cancer.

References

YearCitations

Page 1